2017, Number 3
<< Back Next >>
Rev Mex Urol 2017; 77 (3)
Transperitoneal laparoscopic approach in adrenal myelolipoma
Pineda-Murillo J, Vergara-Vizuet J, Hernández-León O, Torres-Aguilar J, Viveros-Contreras C, Marín-Guizar DM
Language: Spanish
References: 22
Page: 213-218
PDF size: 215.33 Kb.
ABSTRACT
Introduction: Adrenal lipomatous tumors are rare hormonally
silent lesions with an incidence of 4-5%. Myelolipoma is the most common
fatty tumor of the adrenal gland. Adrenal myelolipoma etiology is
still unknown. Myelolipomas are composed of an unusual mixture of
mature adipose tissue and relatively normal trilineage hematopoietic
elements. The aim of our report was to describe a case of adrenal
myelolipoma and its medical approach.
Clinical case: A 64-year-old woman presented with right lumbar
pain of 6-month progression, accompanied with early satiety and an
8-kg weight loss. A multi-detector computed tomography urography
scan showed the presence of a single right adrenal lesion with no
involvement of the ipsilateral upper kidney pole and no enhancement
with the application of contrast medium. Right transperitoneal laparoscopic
adrenalectomy was performed, revealing adrenal myelolipoma.
REFERENCES
Brian CA, Isaac RF. Adrenal Imaging and Intervention. Radiol Clin N Am 2015;(53):1021-1035.
Wein JA, Kavoussi RL, Partin WA, et al. Campbell-Walsh Urología. 11ª Ed. China: Elsevier; 2016.
Martínez-Cornelio A, Hernández-Toriz N, Alvarado-Cabrero I, et al. Mielolipoma suprarrenal, revisión de casos en México. Rev Mex Urol 2008;68(6):334-340.
Sz-Wen H, Kenneth S, Wei-Ching L, et al. Adrenal myelolipoma: A 10-year single-center experience and literature review. Kaohsiung J Med Sci 2012;(28):377-382.
Ramírez M, Misra S. Adrenal myelolipoma: To operate or not? A case report and review of the literature. Int J Surg Case Rep 2014;(5):494-496.
Olivar-Roldán J, Molina-Baena B, Pavón De Paz I, et al. Mielolipoma adrenal gigante: revisión a propósito de un caso. Endocrinol Nutr 2008;55(3):139-41.
Olobatuyi FA, MacLennan GT. Myelolipoma. J Urol 2006;(176):1188.
Khater N, Khauli R. Myelolipomas and other fatty tumours of the adrenals. Arab J Urol 2011;(9):259-265.
Jia-Hwia W. Detection and Treatment of Adrenal Myelolipomas. Urol Sci 2011;22(1):38-39.
Zuviri-González A, Espinosa-Pérez G, Guzmán-Hernández F, et al. Mielolipoma supradrenal. Rev Mex Urol 2011;71(3):188-191.
Daneshmand S, Quek ML. Adrenal Myelolipoma: Diagnosis and Management. J Urol 2006;3(2):71-74.
Cantellano-Orozco M, Merayo-Chalico C, Shuck-Bello C, et al. Patología quirúrgica de la glándula suprarrenal en 20 años: casos del Hospital General Dr. Manuel Gea González. Rev Mex Urol 2009;69(5):238-242.
Kumar S, Jayant K, Prasad S, et al. Rare adrenal gland emergencies: A case series of giant myelolipoma presenting with massive hemorrhage and abscess. Nephro Urol Mon 2015;7(1):e22671.
Da-Rae K, Yoon Young J, Myung-Won Y, et al. Adrenal Myelolipoma Presenting with Spontaneous Rupture and Retroperitoneal Hemorrhage: A Case Report. J Korean Soc Radiol 2016;75(4):296-299.
Young WF. The Incidentally Discovered Adrenal Mass. N Engl J Med 2007;(356):601-610.
Zeiger MA, Thompson GB, Duh QY. AACE/AAES Adrenal Incidentaloma Guidelines. Endocr Pract 2009;15(1):1-20.
Baltzer P, Clauser P, Klatte T, et al. Work-up of the Incidental Adrenal Mass. Eur Urol Focus 2016;(1):217-222.
Fassnacht M, Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2016;(175):1-34.
Virseda JA, Ruiz-Mondéjar R, Donate MJ, et al. Suprarrenalectomía laparoscópica transperitoneal. Actas Urol Esp 2011;35(9):546-551.
Yamashita S, Ito K, Furushima K, et al. Laparoscopic versus open adrenalectomy for adrenal myelolipoma. Ann Med Surg 2014;(3):34-38.
Todorov G, Lukanova T, Georgiev M. Surgical treatment of adrenal myelolipoma. J Clin Med 2010;3(3):24-30.
Kumar V, Abbas A, Fausto N. Robbins y Cotran, Patología estructural y funcional. 7ª Ed. España: Elsevier; 2008.